Skip to main content
SpringerLink
Log in

A clinicopathological evaluation of anti-fucosylated antigens antibody (YB-2) in colorectal carcinoma

  • Research Papers
  • Published:
Glycosylation & Disease

Abstract

A newly generated monoclonal antibody, YB-2, reacts simultaneously with Y (Fucα1→2Galβ1→4[Fucα1→3]GlcNAcβ), Leb (fucα1→2Galβ1→3[Fucα1→4]GlcNAcβ) and H type 2 (Fucα1→2Galβ1→4GlcNAcβ) antigens (Jpn J Cancer Res 1993: 84; 641-8). Since these antigens have been reported to be expressed strongly in malignant colorectal tissues, we investigated the usefulness of this antibody as an immunochemical tool for diagnosis of colorectal cancer. The rate of positive staining with YB-2 antibody in colorectal carcinoma (n=101), adenoma (n=26) and normal tissues (n=25) was 95.0, 50.0 and 12.0%, respectively. The specimens with negative staining were restricted in Dukes' A patients but 75% of Dukes' C patients were strongly positive. The intensity of positive staining with YB-2 antibody was also significantly related to the clinico-pathological features such as the depth of invasion, metastasis, histological types and tumor location. Moreover, the 5-year survival in patients whose tumors were positive with YB-2 antibody was found to be significantly low. Therefore, YB-2 antibody could be useful for immunodiagnosis and, possibly, immunotherapy of colorectal carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hakomori S. Aberrant glycosylation in tumors and tumor associated carbohydrate antigens.Adv Cancer Res 1989:52; 257–331.

    Article  CAS  PubMed  Google Scholar 

  2. Hakomori S. Blood group glycolipid antigens and their modifications as human cancer antigens.Am J Clin Pathol 1984:82; 635–48.

    CAS  PubMed  Google Scholar 

  3. Coon JS, Weinstein RS. Blood grouprelated antigens as markers of malignant potential and heterogeneity in human patient.Human Pathol 1986:17; 1089–105.

    Article  CAS  Google Scholar 

  4. Lloyd KO. Blood group antigens as markers for normal differentiation and malignant changes in human tissues.Am J Clin Pathol 1987:87; 129–39.

    CAS  PubMed  Google Scholar 

  5. Hoff SD, Irimura T, Matsushita Y, et al. Metastatic potential of colon carcinoma.Arch Surg 1990:125; 206–9.

    Article  CAS  PubMed  Google Scholar 

  6. Phillips ML, Nudelman E, Gaeta FCA, et al. ELAM-1 mediates cell adhesion by regulation of carbohydrate ligand, sialyl-Lex.Science 1990:250; 1130–32.

    Article  CAS  PubMed  Google Scholar 

  7. Miyake M, Hakomori S. A specific cell surface glycoconjugate controlling cell motility.Biochemsitry 1991:30; 3328–34.

    Article  CAS  Google Scholar 

  8. Polley MJ, Phillips ML, Wayner E, et al. CD62 and endothelial cell-leukocyte adhesion molecular 1 (ELAM-1) recognizes the same carbohydrate ligand, sialyl-Lewis X.Proc Natl Acad Sci USA 1991:88; 6224–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Takada A, Ohmori K, Takahashi N, et al. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A.Biochem Biophys Res Commun 1991:179; 713–9.

    Article  CAS  PubMed  Google Scholar 

  10. Kojima N, Honda K, Newman W, et al. Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blockingO-glycosylation of these cells.Biochem Biophys Res Commun 1992:182; 1288–95.

    Article  CAS  PubMed  Google Scholar 

  11. Hakomori S and Andrews HD. Sphingoglycolipids with Leb activity, and the co-presence of Lea-, Leb-glycolipids in human tumor tissues.Biochim Biophys Acta 1970:202; 225–8.

    Article  CAS  PubMed  Google Scholar 

  12. Yuan M, Itzkowits SH, Palelar A, et al. Distribution of blood group antigenes A, B, H, Lewisa and Lewisb in human normal fetal, and malignant colonic tissue.Cancer Res 1985:45; 4499–4511.

    CAS  PubMed  Google Scholar 

  13. Sakamoto J, Furukawa K, Cordon-Cardo C, et al. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumor and normal tissue and in human tumor derived cell lines.Cancer Res 1986:46; 1553–61.

    CAS  PubMed  Google Scholar 

  14. Compton C, Wyatte R, Konugres A, et al. Immunohistochemical studies of blood group substance H in colorectal tumors using a monoclonal antibody.Cancer 1987:59; 118–27.

    Article  CAS  PubMed  Google Scholar 

  15. Yazawa S, Akamatsu S, Tachikawa T, et al. Development and characterization of a novel antifucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer.Jpn J Cancer Res 1993:84; 641–8.

    Article  CAS  PubMed  Google Scholar 

  16. Yazawa S, Asao T, Izawa H, Miyamoto Y, Matta KL. The presence of CA19-9 in serum and saliva from Lewis blood-group negative cancer patients.Jpn J Cancer Res 1988:79; 538–43.

    Article  CAS  PubMed  Google Scholar 

  17. Yazawa S, Nakamura J, Asao T, et al. Aberrant α1→2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors.Jpn J Cancer Res 1993:84; 989–95.

    Article  CAS  PubMed  Google Scholar 

  18. Japanese Research Society for Cancer of Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum, and anus.Jpn J Surg 1983:13; 557–73.

    Article  Google Scholar 

  19. Hsu S, Reine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques.J Histochem Cytochem 1987:29 577–80.

    Article  Google Scholar 

  20. Hakomori S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspective.Cancer Res 1985:45; 2405–14.

    CAS  PubMed  Google Scholar 

  21. Hakomori S. Tumor-associated glycolipid antigens, their metabolism and organization.Chem. Phys Lipids 1986:42; 209–33.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Surgery, School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi 371, Gunma, Japan

    Hiroshi Naitoh & Yukio Nagamachi

  2. Department of Pathology, School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi 371, Gunma, Japan

    Takashi Nakajima

  3. Department of Legal Medicine, School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi 371, Gunma, Japan

    Shin Yazawa

Authors
  1. Hiroshi Naitoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yukio Nagamachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shin Yazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naitoh, H., Nakajima, T., Nagamachi, Y. et al. A clinicopathological evaluation of anti-fucosylated antigens antibody (YB-2) in colorectal carcinoma. Glycosylation & Disease 1, 31–36 (1994). https://doi.org/10.1007/BF00917466

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917466

Key words

Search

Navigation